Skip to main content
SpringerLink
Log in

Cilazapril

A Review

  • Published:
Drugs Aims and scope Submit manuscript

Summary

Cilazapril is a new nonthiol group containing angiotensin converting enzyme (AGE) inhibitor, which was designed by a computer-modelling technique in order to obtain a compound with high specificity and selectivity for the target enzyme.

Cilazapril has been investigated in more than 4000 patients with all degrees of hypertension, as well as in special patient groups such as the elderly, renally impaired, and patients with concomitant diseases, such as congestive cardiac failure or chronic obstructive pulmonary disease. In these studies, the blood pressure-lowering effect of a single daily dose has been clearly established. The tolerability profile is similar to other frequently prescribed antihypertensive drugs, such as sustained-release propranolol, enalapril, captopril, atenolol and hydrochlorothiazide. Recently, investigations have revealed that cilazapril, in addition to its blood pressure-lowering abilities, can moderate the proliferative response seen in vessels after vascular injury caused by techniques such as ballooning. Clinical studies to verify these findings are currently ongoing.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Belz GG, Essig J, Wellstein A. Hemodynamic responses to angiotensin I in normal volunteers and the antagonism by the angiotensin-converting enzyme inhibitor cilazapril. Journal of Cardiovascular Pharmacology 9: 219–224, 1987

    Article  PubMed  CAS  Google Scholar 

  • Dzau VJ. Autocrine-paracrine renin-angiotensin systems in cardiorenal regulation and the pharmacology of ACE inhibitors. In Sonneblick EH, Laragh JH, Lesch M (Eds) New frontiers in cardiovascular therapy: focus on angiotensin converting enzyme inhibition, pp. 13–28, Excerpta Medica, Princeton, 1989

    Google Scholar 

  • Dzau VJ. Vascular renin-angiotensin system in hypertension. New insights into the mechanism of action of angiotensin converting enzyme inhibitors. American Journal of Medicine 84 (Suppl. 4A): 4–8, 1988

    PubMed  CAS  Google Scholar 

  • Fasanella d’Amore T, Bussien JP, Nussberger J, Waeber B, Turini GA, et al. Effects of single doses of the converting enzyme inhibitor cilazapril in normal volunteers. Journal of Cardiovascular Pharmacology 9: 26–31, 1987

    PubMed  Google Scholar 

  • Francis RJ, Brown AN, Kler L, Fasanella d’Amore T, Nussberger J, et al. Pharmacokinetics of the converting enzyme inhibitor cilazapril in normal volunteers and the relationship to enzyme inhibition: development of a mathematical model. Journal of Cardiovascular Pharmacology 9: 32–38, 1987

    PubMed  CAS  Google Scholar 

  • Goldszer RC, Rodriguez R, Soloman HS. Efficacy and safety of cilazapril, a new angiotensin-converting enzyme inhibitor. American Journal of Hypertension 1: 300S–302S, 1988

    PubMed  CAS  Google Scholar 

  • Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure: the 1988 report. Archives of Internal Medicine 148: 1023–1038, 1988

    Article  Google Scholar 

  • Laragh JH. The renin system and the impact of ACE inhibition for understanding, diagnosis, and treatment of hypertension. In Sonnenblick EH, Laragh JH, Lesch M (Eds) New frontiers in cardiovascular therapy: focus on angiotensin converting enzyme inhibition, pp. 83–116, Excerpta Medica, Princeton, 1989

    Google Scholar 

  • Nussberger J, Fasanella d’Amore T, Porchet M, Waeber B, Brunner DB, et al. Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteers. Journal of Cardiovascular Pharmacology 9: 39–44, 1987

    PubMed  CAS  Google Scholar 

  • Powell JS, Clozel JP, Müller RKM, Kuhn H, Hefti F, et al. Inhibitors of angiotensin converting enzyme prevent myointimal proliferation after vascular injury. Science 245: 186–188, 1989

    Article  PubMed  CAS  Google Scholar 

  • Sanchez RA, Traballi CA, Barclay CA, Gilbert HB, Muscará M, et al. Antihypertensive, enzymatic, and hormonal activity of cilazapril, a new angiotensin-converting enzyme inhibitor in patients with mild to moderate essential hypertension. Journal of Cardiovascular Pharmacology 11: 230–234, 1988

    PubMed  CAS  Google Scholar 

  • Schoenberger JA. Emerging benefits of angiotensin converting enzyme inhibitors versus other antihypertensive agents. American Journal of Medicine 84 (Suppl. 4A): 30–35, 1988

    PubMed  CAS  Google Scholar 

  • Sealey JE. A separate prorenin-angiotensin system in reproductive and renal tissues? Evidence for renin gene expression in extrarenal vascular tissues is unconvincing. In Sonnenblick EH, Laragh JH, Lesch M (Eds) New frontiers in cardiovascular therapy: focus on angiotensin converting enzyme inhibition, pp. 29–46, Excerpta Medica, Princeton, 1989

    Google Scholar 

  • Tigerstedt R, Bergman PG. Niere und Kreislauf. Scandinavian Archives of Physiology 8: 223–271, 1898

    Article  Google Scholar 

  • Wellstein A, Essig J, Belz GG. Inhibition of angiotensin-I response by cilazapril and its time course in normal volunteers. Clinical Pharmacology and Therapeutics 41: 639–644, 1987

    Article  PubMed  CAS  Google Scholar 

  • White WB, McCabe EJ, Hager WD, Schulman P. The effects of the long-acting angiotensin-converting enzyme inhibitor cilazapril on casual, exercise, and ambulatory blood pressure. Clinical Pharmacology and Therapeutics 44: 173–178, 1988

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. F. Hoffmann-La Roche Ltd, CH-4002, Basel, Switzerland

    Thomas Szucs

Authors
  1. Thomas Szucs
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Szucs, T. Cilazapril. Drugs 41 (Suppl 1), 18–24 (1991). https://doi.org/10.2165/00003495-199100411-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199100411-00005

Keywords

Search

Navigation